|
End-of-day quote
Buenos Aires S.E.
19/08/2026
|
5-day change | 1st Jan Change | ||
| 155.00 ARS | -1.90% |
|
-1.59% | -35.55% |
| Market Cap | 660.14Cr 44.08L 37.81L 35.3L 32.39L 60.91L 42Cr 61.91L 4.17Cr 1.63Cr 21Cr 1.65Cr 1.62Cr 70Cr | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 733.91Cr 49L 42.03L 39.25L 36.01L 67.72L 47Cr 68.83L 4.63Cr 1.81Cr 23Cr 1.84Cr 1.8Cr 78Cr | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.90% | ||
| 1 week | -1.59% | ||
| Current month | -2.82% | ||
| 1 month | -2.21% | ||
| 3 months | -7.46% | ||
| 6 months | -27.57% | ||
| Current year | -35.55% |
| 1 week | 153.5 |  | 162.5 |
| 1 month | 150 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 23 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -1.59% | -22.50% | +520.00% | 45.08L | |
| +3.68% | +4.27% | -50.74% | -57.77% | 3.06TCr | |
| +3.64% | +10.71% | +39.84% | +110.84% | 1.18TCr | |
| -2.19% | -0.70% | -17.53% | +5.74% | 395.5Cr | |
| +0.15% | -0.90% | -1.93% | +21.28% | 320.1Cr | |
| -2.52% | -4.51% | +43.34% | +37.20% | 217.69Cr | |
| +0.86% | +0.43% | +12.26% | +11.90% | 194.05Cr | |
| +2.28% | +4.85% | +11.27% | +133.93% | 140.56Cr | |
| -2.28% | -7.21% | -20.99% | +4.19% | 126.86Cr | |
| -1.91% | +0.30% | -12.91% | -42.95% | 103.12Cr | |
| Average | -0.02% | +0.88% | -1.99% | +74.44% | 573.56Cr | |
| Weighted average by Cap. | +2.47% | +4.38% | -18.51% | -1.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827.49Cr 55.25L 47.39L 44.26L 40.6L 76.35L 53Cr 77.61L 5.22Cr 2.04Cr 26Cr 2.07Cr 2.03Cr 88Cr | 640.36Cr 42.76L 36.68L 34.25L 31.42L 59.09L 41Cr 60.06L 4.04Cr 1.58Cr 20Cr 1.61Cr 1.57Cr 68Cr |
| Net income | -141.73Cr -9L -8L -8L -7L -13.08L -9.05Cr -13.29L -89.44L -35.02L -4.54Cr -35.53L -34.76L -15Cr | -459.77Cr -30.7L -26.33L -24.59L -22.56L -42.42L -29Cr -43.12L -2.9Cr -1.14Cr -15Cr -1.15Cr -1.13Cr -49Cr |
| Net Debt | 86Cr 6L 5L 5L 4L 8L 5.51Cr 8L 54.47L 21.33L 2.76Cr 21.64L 21.17L 9.13Cr | 74Cr 5L 4L 4L 4L 7L 4.71Cr 7L 46.56L 18.23L 2.36Cr 18.5L 18.09L 7.81Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | ARS 155.00 | -1.90% | 6,369 |
| 18/26/18 | ARS 158.00 | +1.28% | 15,265 |
| 14/26/14 | ARS 156.00 | -2.50% | 2,457 |
| 13/26/13 | ARS 160.00 | +1.59% | 5,690 |
| 12/26/12 | ARS 157.50 | -2.78% | 2,404 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
